A case of appendiceal cancer metastatic to the stomach with pseudomyxoma peritonei

Miyashita, Taku; Hoshino, Etsuo; Imamura, Tetsuo; Okinaga, Kouta; Akaoka, Ieo; Miyashita, Hideo

doi:10.1007/bf01229077

Cited by 4 publications

(6 citation statements)

References 12 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Metastatic gastric tumors may originate from various organs [9, 10, 11, 12, 13, 14, 15, 16, 17] but are most common from breast, lung, and esophageal cancers and melanoma [4, 5]. Oda et al reported that malignant melanoma was the most common tumor to metastasize to the stomach [5].…”

Section: Discussionmentioning

confidence: 99%

“…Pector et al reported a patient who had been alive more than 6 years after subtotal gastrectomy for MGT from malignant melanoma [31]. Less invasive treatment, such as endoscopic resection of the MGT, was reported to be feasible for renal cell carcinoma [10] and appendiceal cancer [12]. Saito et al suggested that surgical resection be performed when an MGT from esophageal cancer is limited to the stomach and is < 2 cm because the mean survival time after treatment for MGT is extremely short [7].…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Clinical Diagnosis of Metastatic Gastric Tumors: Clinicopathologic Findings and Prognosis of Nine Patients in a Single Cancer Center

et al. 2004

View full text Add to dashboard Cite

The clinical features of metastatic gastric tumors (MGTs) have not been well documented. We present a clinical series of nine patients with MGTs. Among 2579 patients with gastric tumors seen between 1992 and 2001, we studied 9 (0.3%) patients with MGT according to a prospective database. The MGTs were diagnosed based on findings in the surgical or endoscopic specimen, and patients with malignant lymphoma or direct invasion from adjacent organs were excluded from the study. MGTs were detected simultaneously with the primary tumors in three and afterward in six patients at 14 to 74 months. The primary tumors included one each of squamous cell carcinoma of the esophagus, signet-ring cell carcinoma of the breast, large-cell or small-cell carcinoma of the lung, renal cell carcinoma, hepatocellular carcinoma, squamous cell or epidermoid carcinoma of the uterus, and melanoma. Multiple organ metastases were present simultaneously in six patients. Although six patients underwent gastrectomy, macroscopic eradication of gastric metastatic disease was accomplished in only four, in whom a UICC R0 resection was possible in only two. Five patients were treated by chemotherapy with no apparent survival benefit. A median survival after MGT diagnosis was 170 days (range 16-892 days) for all cases, 384 days for those who underwent gastrectomy (n = 6), and 27 days for those without active treatment (n = 3) (p = 0.002). The cause of death was multiple organ metastases in most cases. Because multiple metastases are common, the prognosis of MGT is poor even after curative resection. MGT is likely to be a preterminal event, and surgical resection may be useful only for palliation.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

Clinical Diagnosis of Metastatic Gastric Tumors: Clinicopathologic Findings and Prognosis of Nine Patients in a Single Cancer Center

et al. 2004

View full text Add to dashboard Cite

show abstract

“…Miyashita et al 13 reported the first case of appendiceal cancer with psudomyxoma peritonei that metastasized to the stomach. The tumor was endoscopically removed and diagnosed.…”

Section: Discussionmentioning

confidence: 98%

“…Only 12 cases of distant metastasis have been reported. [11][12][13][14][15][16] These include pleural metastasis with invasion of the thoracic wall; invasion of the pleural cavities, possibly due to spread through a diaphragmatic defect; pulmonary metastasis; invasion of an axillary lymph node; subcutaneous localization in the thoracic wall; metastasis in the periaortic lymph node; metastasis in the liver, pancreas, urinary bladder, periaortic lymph node, pleura, and pericardium; two cases of metastasis in the spleen; metastasis in the brain and lung; metastasis in the diaphragm, liver, gallbladder, spleen, and kidney; and metastasis in the stomach. The lymph nodes, lungs, spleen, and liver are possible metastatic sites, and both hematogenous metastasis and lymphatic metastasis have been considered possible.…”

Section: Discussionmentioning

confidence: 99%

Pseudomyxoma Peritonei of Appendiceal Cancer with Metastasis to the Stomach: Report of a Case

et al. 2002

View full text Add to dashboard Cite

Appendiceal cancer associated with pseudomyxoma peritonei is a relatively low-grade malignancy rarely associated with extraperitoneal metastasis. We report herein the case of a 71-year-old man in whom a metastasis was found in the stomach 2 years after he underwent surgery for pseudomyxoma peritonei of appendiceal cancer. He was referred to our hospital after presenting with anorexia and vomiting. Gastrofiberscopy, abdominal computed tomography, and ultrasound examination all revealed a mass 4 x 4cm in size, containing a small ulcer, in the antrum of the greater curvature of the stomach. The histopathological diagnosis made from a biopsy of the tumor was mucinous cystadenocarcinoma. A distal partial gastrectomy was performed and the resected specimens from the appendiceal cancer resected 2 years earlier showed the same histological pattern as that of the gastric lesion. To the best of our knowledge, this is only the second report of pseudomyxoma peritonei secondary to mucinous cystadenocarcinoma of the appendix that metastasized to the stomach.

show abstract

“… 3 However, metastatic primary appendiceal cancer to the GI tract is rare, and only two cases of gastric metastases have been reported. 4 5 However, small bowel metastases caused by primary appendiceal cancer have never been reported in the literature. Our patient had histologically proven small intestinal lesions originating from primary appendiceal adenocarcinoma.…”

Section: Discussionmentioning

confidence: 99%

Capsule retention caused by duodenal metastases from primary appendiceal adenocarcinoma

Chou

Cheng

2017

Intest Res

View full text Add to dashboard Cite

Metastatic small bowel cancers are extremely rare in clinical practice. Primary appendiceal adenocarcinoma with gastrointestinal metastasis is seldom reported in the literature. Here, we describe the case of an 80-year-old male patient with primary appendiceal adenocarcinoma, who presented to China Medical University Hospital with mid-gastrointestinal tract bleeding. Capsule endoscopy revealed stenotic bowel lumen, but the capsule was retained in the distal duodenum. Double-balloon enteroscopy demonstrated erosive and erythematous mucosa in the region of capsule retention. The retained capsule was retrieved successfully by using an electrosurgical snare. Histological examination and immunohistochemical staining of the biopsy specimen from the duodenal lesion strongly supported the diagnosis of metastatic appendiceal adenocarcinoma.

show abstract

A case of appendiceal cancer metastatic to the stomach with pseudomyxoma peritonei

Cited by 4 publications

References 12 publications

Clinical Diagnosis of Metastatic Gastric Tumors: Clinicopathologic Findings and Prognosis of Nine Patients in a Single Cancer Center

Clinical Diagnosis of Metastatic Gastric Tumors: Clinicopathologic Findings and Prognosis of Nine Patients in a Single Cancer Center

Pseudomyxoma Peritonei of Appendiceal Cancer with Metastasis to the Stomach: Report of a Case

Capsule retention caused by duodenal metastases from primary appendiceal adenocarcinoma

Contact Info

Product

Resources

About